港股異動丨文化傳信(0343.HK)復牌大漲12.5% 購中文人工智能企業
格隆匯6月3日丨文化傳信(0343.HK)復牌大漲12.5%,報0.495港元,高見0.55港元創逾三年新高,最新總市值8億港元。文化傳信公佈,公司擬6300萬港元收購仿腦科技(深圳)全部股份,將透過發行及配發代價股份方式償付。該公司將按每股約0.33港元發行1.91億股代價股份,發行價較停牌前收市價0.44港元折讓約25%,代價股份相當於該公司經擴大後股本約10.27%。仿腦科技主要從事開發及銷售人工智能硬件及軟件,專注於中文人工智能語言處理、中文自然語言理解和中文人工智能底層技術研發和商業化發展。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.